Future in precise surgery: Fluorescence-guided surgery using EVs derived fluorescence contrast agent

Surgery is the only cure for many solid tumors, but positive resection margins, damage to vital nerves, vessels and organs during surgery, and the range and extent of lymph node dissection are significant concerns which hinder the development of surgery. The emergence of fluorescence-guided surgery...

Full description

Saved in:
Bibliographic Details
Published in:Journal of controlled release 2023-01, Vol.353, p.832-841
Main Authors: Sun, Jian-Xuan, Xu, Jin-Zhou, An, Ye, Ma, Si-Yang, Liu, Chen-Qian, Zhang, Si-Han, Luan, Yang, Wang, Shao-Gang, Xia, Qi-Dong
Format: Article
Language:English
Subjects:
Contrast Media - analysis
Drug delivery
Drug Delivery Systems
Engineered EV
Exosome
Extracellular vesicles
Extracellular Vesicles - chemistry
Fluorescence
Fluorescence-guided surgery
Humans
Neoplasms - diagnostic imaging
Neoplasms - surgery
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Surgery is the only cure for many solid tumors, but positive resection margins, damage to vital nerves, vessels and organs during surgery, and the range and extent of lymph node dissection are significant concerns which hinder the development of surgery. The emergence of fluorescence-guided surgery (FGS) means a farewell to the era when surgeons relied only on visual and tactile feedback, and it gives surgeons another eye to distinguish tumors from normal tissues for precise resection and helps to find a balance between complete tumor lesions removal and maximal organ function conservation. However, the existing synthetic fluorescence contrast agent has flaws in safety, specificity and biocompatibility to various extents. Extracellular vesicles (EVs) are a group of heterogeneous types of cell-derived membranous structures present in all biological fluids. EVs, especially engineered targeting EVs, play an increasingly important role in drug delivery because of their good biocompatibility, validated safety and targeting ability. Nevertheless, few studies have employed EVs loaded with fluorophores to construct fluorescence contrast agents and used them in FGS. Here, we systematically reviewed the current state of knowledge regarding FGS, fundamental characteristics of EVs, and the development of engineered targeting EVs, and put forward a novel strategy and procedures to produce EVs-based fluorescence contrast agent used in fluorescence-guided surgery. The definition, design, and application scheme of EVs-base fluorescence-guided surgery. [Display omitted]
ISSN:0168-3659
1873-4995
DOI:10.1016/j.jconrel.2022.12.013